These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31740368)

  • 1. Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trial.
    Demidowich AP; Wolska A; Wilson SR; Levine JA; Sorokin AV; Brady SM; Remaley AT; Yanovski JA
    J Clin Lipidol; 2019; 13(6):1016-1022.e2. PubMed ID: 31740368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
    Demidowich AP; Levine JA; Apps R; Cheung FK; Chen J; Fantoni G; ; Patel TP; Yanovski JA
    Int J Obes (Lond); 2020 Aug; 44(8):1793-1799. PubMed ID: 32461554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome.
    Levine JA; Sarrafan-Chaharsoughi Z; Patel TP; Brady SM; Chivukula KK; Miller E; Han JM; Periwal V; Wolska A; Remaley AT; Dagur PK; Biancotto A; Babyak A; Fantoni G; Yanovski JA; Demidowich AP
    Obesity (Silver Spring); 2022 Feb; 30(2):358-368. PubMed ID: 34978374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight loss achieved by bariatric surgery modifies high-density lipoprotein subfractions and low-density lipoprotein oxidation towards atheroprotection.
    Coimbra S; Reis F; Ferreira C; Nunes S; Viana S; Catarino A; Rocha-Pereira P; Belo L; Monteiro L; Catarino C; Santos-Silva A
    Clin Biochem; 2019 Jan; 63():46-53. PubMed ID: 30342017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial.
    Otvos JD; Guyton JR; Connelly MA; Akapame S; Bittner V; Kopecky SL; Lacy M; Marcovina SM; Muhlestein JB; Boden WE
    J Clin Lipidol; 2018; 12(2):348-355.e2. PubMed ID: 29409728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter?
    Phillips CM; Perry IJ
    Atherosclerosis; 2015 Oct; 242(2):399-406. PubMed ID: 26277632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy.
    Koren MJ; Kereiakes D; Pourfarzib R; Winegar D; Banerjee P; Hamon S; Hanotin C; McKenney JM
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26586732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Pitavastatin on Lipoprotein Subfractions and Oxidized Low-density Lipoprotein in Patients with Atherosclerosis.
    Xu RX; Zhang Y; Zhang Y; Wu YR; Li XL; Guo YL; Liu G; Dong Q; Li JJ
    Curr Med Sci; 2020 Oct; 40(5):879-884. PubMed ID: 33123903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial.
    Demidowich AP; Levine JA; Onyekaba GI; Khan SM; Chen KY; Brady SM; Broadney MM; Yanovski JA
    Diabetes Obes Metab; 2019 Jul; 21(7):1642-1651. PubMed ID: 30869182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA
    Hermans N; Van der Auwera A; Breynaert A; Verlaet A; De Bruyne T; Van Gaal L; Pieters L; Verhoeven V
    Trials; 2017 Jul; 18(1):302. PubMed ID: 28673363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
    Boczar KE; Shin S; deKemp RA; Dowlatshahi D; Tavoosi A; Wiefels C; Liu P; Lochnan H; MacPherson PA; Chong AY; Torres C; Leung E; Tawakol A; Ahmadi A; Garrard L; Lefebvre C; Kelly C; MacPhee P; Tilokee E; Raggi P; Wells GA; Beanlands R
    BMJ Open; 2023 Nov; 13(11):e074463. PubMed ID: 37949621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Oxidized High-Density Lipoprotein/High-Density Lipoprotein-Cholesterol Ratio as a Potential Indicator of Disturbed Metabolic Health in Overweight and Obese Individuals.
    Janac JM; Zeljkovic A; Jelic-Ivanovic ZD; Dimitrijevic-Sreckovic VS; Vekic J; Miljkovic MM; Stefanovic A; Kotur-Stevuljevic JM; Ivanisevic JM; Spasojevic-Kalimanovska VV
    Lab Med; 2020 Jan; 51(1):24-33. PubMed ID: 31089722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
    Anholm C; Kumarathurai P; Pedersen LR; Samkani A; Walzem RL; Nielsen OW; Kristiansen OP; Fenger M; Madsbad S; Sajadieh A; Haugaard SB
    Atherosclerosis; 2019 Sep; 288():60-66. PubMed ID: 31326727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B, oxidized low-density lipoprotein, and LDL particle size in predicting the incidence of metabolic syndrome: the Cardiovascular Risk in Young Finns study.
    Koskinen J; Magnussen CG; Würtz P; Soininen P; Kangas AJ; Viikari JS; Kähönen M; Loo BM; Jula A; Ahotupa M; Lehtimäki T; Ala-Korpela M; Juonala M; Raitakari OT
    Eur J Prev Cardiol; 2012 Dec; 19(6):1296-303. PubMed ID: 21960651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum oxLDL-β2GPI complex reflects metabolic syndrome and inflammation in adipose tissue in obese.
    Siklova M; Koc M; Rossmeislová L; Kraml P
    Int J Obes (Lond); 2018 Mar; 42(3):405-411. PubMed ID: 29081508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).
    Guyton JR; Slee AE; Anderson T; Fleg JL; Goldberg RB; Kashyap ML; Marcovina SM; Nash SD; O'Brien KD; Weintraub WS; Xu P; Zhao XQ; Boden WE
    J Am Coll Cardiol; 2013 Oct; 62(17):1580-4. PubMed ID: 23916935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker.
    Berends AMA; Buitenwerf E; Gruppen EG; Sluiter WJ; Bakker SJL; Connelly MA; Kerstens MN; Dullaart RPF
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):79-87. PubMed ID: 30372543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is oxidized low-density lipoprotein the connection between atherosclerosis, cardiovascular risk and nephrolithiasis?
    de Freitas ACP; Torres LC; Duarte MDCMB; da Matta MC; Casarini DE; Schor N
    Urolithiasis; 2019 Aug; 47(4):347-356. PubMed ID: 30302491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.